BioNTech SE - ADR vs IAC/Interactivecorp — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while IAC/Interactivecorp trades at $40.01 (market cap $2.97B). The key difference: BioNTech SE - ADR is far larger — about 7.8× IAC/Interactivecorp's market cap, and IAC/Interactivecorp is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| BNTX | PPLI | |
|---|---|---|
Market Cap | $23.31B | $2.97B |
Sector | Health | Media |
52-Week High | $119.34 | $47.62 |
52-Week Low | $83.89 | $31.52 |
Enterprise Value | $6.60B | $3.28B |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →IAC Inc is an Internet media company with segments that include Angi (47% of total revenue), Dotdash (10%), search (24%), and emerging and other (19%). The firm spun off the narrow-moat dating app provider Match Group in second-quarter 2020 and the no-moat video software provider Vimeo in second-quarter 2021.
Read more on PPLI →